THE WHAT? Kao has announced that it is set to commercialize the Skin Surface Lipids-RNA Monitoring Technology it has developed, partnering with Healthcare Systems to launch a new mail-in testing service.

THE DETAILS Babywell Check as the new venture has been named will offer parents a non-invasive method for collecting sebum to gain information about the barrier functions of infants’ skin.

THE WHY? With this testing service, parents can learn about a child’s skin condition and appropriate care to ensure their child’s healthy development.